The expression levels of GP73, TGF‐β1 and Smad2 in HG urothelial carcinomas were significantly higher than those in LMP papillary urothelial cancers and LG urothelial carcinomas (all P < 0.05). This evidence concerns the gene SMAD2 and urothelial carcinoma.